Arkley Biotek

Indianapolis, IN

Arkley Biotek LLC is developing blood-based diagnostics for early detection of Alzheimer’s disease. The company plans to use redox-reactive autoantibodies (R-RAA) as an early non-invasive marker for Alzheimer’s disease in patients suffering from Mild Cognitive Impairment.

Member Number: 64, Basic